Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 11/20 | 0.45 |
| ▸ | PPARA | Q07869 | 9/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14653108 | 0.89 | TRPA1 (0.44) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL19758123 | 0.89 | TRPA1 (0.44) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL17896199 | 0.89 | TRPA1 (0.44) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL7966638 | 0.81 | CYP1A2 (0.58) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL7976612 | 0.81 | CYP1A2 (0.58) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL11752459 | 0.81 | CYP1A2 (0.58) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL23647523 | 0.78 | POLB (0.45) | CYP1A2GAACYP2C9CYP2C19PPARG | |
| SCHEMBL7978503 | 0.78 | LDHA (0.44) | GAAMAPTPPARGPPARASMN1; SMN2 | |
| SCHEMBL7987487 | 0.76 | ALDH1A1 (0.44) | PKMPPARGPPARAALOX15 | |
| SCHEMBL9141117 | 0.76 | LMNA (0.47) | CYP1A2GAACYP2C9PKMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6300352-B1 | FOR THERAPY OF ASTHMA | ASTRAZENECA AB (SE) | 2001-10-09 | — | — | US | disclosed |
| EP-0971892-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Astra Pharmaceuticals Limited (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042670-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ASTRA PHARMACEUTICALS LTD. (GB) | 1998-10-01 | — | — | WO | disclosed |